A group of Republicans and Democrats in the House and Senate is asking the Health Resources and Services Administration (HRSA) to finalize regulations around drug ceiling prices and penalties for manufacturers that overcharge the 340B program.
House and Senate leaders push HRSA to finalize 340B regulations on drug pricing, penalties
